Mednax Inc Stock
Mednax Inc Stock
We can see a decrease in the price for Mednax Inc. Compared to yesterday it has lost -€0.400 (-1.740%).
Our community identified positive and negative aspects for Mednax Inc stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Mednax Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Mednax Inc in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mednax Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mednax Inc | -1.740% | 2.727% | 4.630% | 111.215% | 22.826% | 85.246% | -8.130% |
| Davita Inc. | -0.340% | 0.531% | 6.906% | 69.268% | 115.886% | 124.402% | 105.325% |
| Chemed Corp. | 2.670% | 5.000% | 13.793% | 28.333% | 26.923% | - | - |
| Molina Healthcare | 0.470% | -2.359% | -15.150% | 22.616% | 16.233% | -38.714% | -26.281% |
Comments
Pediatrix Medical Group (MD) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group (NYSE:MD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) was upgraded by analysts at Zacks Research to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat